Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 276Carcinoma, Non-Small-Cell Lung 243Neoplasms 227Prostatic Neoplasms 185Colorectal Neoplasms 175Multiple Myeloma 135Lung Neoplasms 132Ovarian Neoplasms 118Neoplasm Metastasis 118Leukemia, Myeloid, Acute 107Pancreatic Neoplasms 102Melanoma 90Squamous Cell Carcinoma of Head and Neck 87Recurrence 78Endometrial Neoplasms 75Carcinoma, Renal Cell 71Lymphoma, Non-Hodgkin 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Lymphoma 66Stomach Neoplasms 64Glioblastoma 63Carcinoma, Hepatocellular 63Brain Neoplasms 62Glioma 60Sarcoma 57Head and Neck Neoplasms 57Uterine Cervical Neoplasms 56Triple Negative Breast Neoplasms 55Leukemia, Lymphocytic, Chronic, B-Cell 54Urinary Bladder Neoplasms 50

Interventions

thymoglobulin 1fludarabine 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Dexamethasone 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Anemia, Sickle Cell × 30 days × Clear all
NCT06689800 2026-06-04

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

Washington University School of Medicine

Phase NA Recruiting
60 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Metabolic Diseases, Hematologic Neoplasms

NCT05736419 2026-06-03

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
24 enrolled
Classical hematology

Anemia, Sickle Cell, Thalassemia, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡